Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review

Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review

Backgroud: The co-administration of Chinese patent medicine with calcium channel blockers (CCBs) is a prevalent practice in China for treating essential hypertension (EH). However, robust evidence supporting the efficacy and safety of tailored combinations of different Chinese patent medicines with...

Full description

Bibliographic Details
Main Authors: Liangyu Cui, Xingfang Liu, Yukun Li, Tianyue Jing, Dasheng Liu, Cong Ren, Tong Yin, Yu Wang, Zhiwei Zhao, Jiaheng Wang, Xuejie Han, Liying Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
ethnopharmacological research
calcium channel Blockers(CCBs)
hypertension
network meta-analysis
review studies
therapeutic efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1321405/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1321405/full

Similar Items